Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Testing effectiveness (Phase 2)UnknownNCT06201507
What this trial is testing

BV-AVD-R Treatment Children Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma
Beijing Children's Hospital 44
Testing effectiveness (Phase 2)Study completedNCT01839487
What this trial is testing

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Halozyme Therapeutics 279
Testing effectiveness (Phase 2)Active Not RecruitingNCT04624906
What this trial is testing

Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Sunnybrook Health Sciences Centre 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06516978
What this trial is testing

A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 528
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565378
What this trial is testing

A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 351
Testing effectiveness (Phase 2)WithdrawnNCT01205217
What this trial is testing

Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline
Early research (Phase 1)Looking for participantsNCT07107750
What this trial is testing

Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Metastatic Biliary Tract CancerMetastatic Biliary Tract Carcinoma
Washington University School of Medicine 48
Early research (Phase 1)Ended earlyNCT00156299
What this trial is testing

Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate

Who this might be right for
Leukemia
Rutgers, The State University of New Jersey 15
Testing effectiveness (Phase 2)Study completedNCT01294618
What this trial is testing

Nilotinib + Pegylated Interferon Alpha 2a for Untreated Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Hospices Civils de Lyon 60
Testing effectiveness (Phase 2)Study completedNCT00632749
What this trial is testing

BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment

Who this might be right for
Leukemia, Myeloid, Acute
Boehringer Ingelheim 68
Testing effectiveness (Phase 2)Looking for participantsNCT06471738
What this trial is testing

Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma

Who this might be right for
Ann Arbor Stage II Follicular LymphomaGrade 1 Follicular LymphomaAnn Arbor Stage III Follicular Lymphoma+3 more
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01015248
What this trial is testing

Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

Who this might be right for
MALT LYMPHOMA
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 60
Large-scale testing (Phase 3)UnknownNCT05040906
What this trial is testing

A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

Who this might be right for
Recruiting
Shandong New Time Pharmaceutical Co., LTD 416
Testing effectiveness (Phase 2)Looking for participantsNCT04002947
What this trial is testing

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaDiffuse Large B-Cell LymphomaDLBCL+1 more
National Cancer Institute (NCI) 132
Testing effectiveness (Phase 2)Study completedNCT00005843
What this trial is testing

R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Not applicableLooking for participantsNCT07161310
What this trial is testing

Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

Who this might be right for
Solid CancerNon-Small Cell Lung CancerMelanoma
Goethe University 45
Testing effectiveness (Phase 2)Study completedNCT03788291
What this trial is testing

Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
University of Rochester 39
Testing effectiveness (Phase 2)Looking for participantsNCT07117890
What this trial is testing

Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations

Who this might be right for
Non Small Cell Lung Cancer
Fudan University 34
Next Page